| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/14/2008 | WO2008098208A2 Gnaq mutations in melanoma |
| 08/14/2008 | WO2008098207A2 Method and system for the use of hollow fiber catheters in topical applications |
| 08/14/2008 | WO2008098183A2 Combination therapy for treating cancer |
| 08/14/2008 | WO2008097927A2 Treatment and prevention of neurodegenerative diseases using gene therapy |
| 08/14/2008 | WO2008097926A2 Transient transfection with rna |
| 08/14/2008 | WO2008097885A2 Decellularization of soft tissue |
| 08/14/2008 | WO2008097875A1 Novel methods for treating neurodegenerative disorders |
| 08/14/2008 | WO2008097854A2 Method and substances for treating hpv infection |
| 08/14/2008 | WO2008097623A2 Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy |
| 08/14/2008 | WO2008097503A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 08/14/2008 | WO2008097267A2 Vaccines against vesicular stomatitis |
| 08/14/2008 | WO2008096690A1 Polyethylene glycol derivative |
| 08/14/2008 | WO2008095735A1 Use of sirt7 for treating age-related diseases |
| 08/14/2008 | WO2008095356A1 Methods of diagnosis of spinal muscular atrophy and treatments thereof |
| 08/14/2008 | WO2008064056A9 Tetracycline repressor and uses thereof |
| 08/14/2008 | WO2008063773A9 Combinatorial treatment with epidermal growth factor receptor inhibitor molecules and melanoma differentiation associated gene-7 |
| 08/14/2008 | WO2008033375A3 Long lasting drug formulations |
| 08/14/2008 | WO2008026223B1 An aqueous formulation for selective targeting and delivering gene to cancer cells |
| 08/14/2008 | WO2008015383A3 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 08/14/2008 | WO2006133135A3 Herpes virus-based compositions and methods of use |
| 08/14/2008 | US20080194682 administering inhibitors of endopeptidase such as thiorphan or candoxatril, to effect bone elongation; achondroplasia |
| 08/14/2008 | US20080194540 Desipramine, imipramine, trimipramine, amitriptyline, nortriptyline, doxepin, amoxapine, or maprotyline and chloroquine, promazine, quinine, biquinoline, phenothiazine or chlorpromazine; transfection or gene therapy |
| 08/14/2008 | US20080194514 Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences |
| 08/14/2008 | US20080194511 Encoding somatoliberin (GHRH) and comprising a eukaryotic promoter; a 5' untranslated region, a codon-optimized-eukaryotic therapeutic gene sequence, and a polyadenylation signal; plasmid mediated gene supplementation |
| 08/14/2008 | US20080194491 Methods of Diagnosing, Preventing, and Treating Early Onset of Pulmonary Hypertension |
| 08/14/2008 | US20080194474 Increasing the population of HSA+/Ly6C+ cells in bone marrow with Fms-like tyrosine kinase 3 ligand (Flt3-Ligand); preventing or delaying type I diabetes, rheumatoid arthritis, lupus, multiple sclerosis, psoriasis, scleroderma, inflammatory bowel diseases, or myasthenia gravis; bone marrow transplant |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080194002 Buffered polyhydroxy hydrocarbon solution comprising adenoviral vector; enhanced stability; gene therapy |
| 08/14/2008 | US20080193949 Using selectin concentration as diagnostic indicator of thrombosis |
| 08/14/2008 | US20080193515 Overexpression of Wnt ligands and treatment of lytic bone diseases |
| 08/14/2008 | US20080193484 Novel Methods for Producing Adenoviral Vector Preparations with Reduced Replication-Competent Adenovirus Contamination and Novel Adenoviral Vectors and Preparations |
| 08/14/2008 | US20080193483 Modified vaccinia Ankara (MVA); replication-deficient strain of vaccinia virus; poxvirus |
| 08/14/2008 | US20080193463 Combating the pathogenic effects of Mycoplasma infection in an animal by administering an effective amount of isolated and purified mycoplasmal L-alpha-glycerophosphate oxidase or an immunogenic fragment thereof, and a pharmaceutically acceptable carrier |
| 08/14/2008 | US20080193462 Inhibiting tumor cell growth in subject by administering to said subject a combination of a cytotoxic or a chemotherapeutic agent and a composition comprising an insulin-like growth factor receptor-1 (IGF-1R) inhibitor; demonstrating specific approaches to enhance therapeutic window of IGF-1R inhibition |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193444 Methods of suppressing LTP inhibition |
| 08/14/2008 | US20080193443 Using connective tissue growth factor specific immunoglobulin for diagnosis, prevention and treatment of autosomal dominant polycystic kidney disease (ADPKD) |
| 08/14/2008 | US20080193442 Inhibition of complement activation |
| 08/14/2008 | US20080193426 Increasing homing of CD34 by administering chemokines, fusion protein; irradiation, cyclophosphamide or 5-fluorouracil; interleukins; Gaucher disease |
| 08/14/2008 | US20080193420 Method for the Production of a Cell Composition Containing Epithelial Cells |
| 08/14/2008 | US20080193416 Vectors used to generate modified artificial chromosomes; cleavage sites that flank origin of replication, antibiotic resistance gene and sequence that encodes fluorescent protein |
| 08/14/2008 | US20080193414 Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| 08/14/2008 | US20080193373 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 08/14/2008 | DE102007005946A1 Therapeutische Zusammensetzung und Verwendung einer zellfreien Substanz The therapeutic composition and use of a cell-free substance |
| 08/14/2008 | CA2677799A1 Gnaq mutations in melanoma |
| 08/14/2008 | CA2677273A1 Use of a composition comprising a cytokine encoding nucleic acid for treating alzheimer's disease |
| 08/14/2008 | CA2677229A1 Decellularization of soft tissue |
| 08/14/2008 | CA2677228A1 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 08/13/2008 | EP1956094A1 Promoters for expression in modified vaccinia virus ankara |
| 08/13/2008 | EP1956093A1 von Willebrand Factor (vWF)-cleaving protease |
| 08/13/2008 | EP1956080A2 Use of common gamma chain cytokines for the genetic modification of memory T lymphocytes |
| 08/13/2008 | EP1956079A1 Neural progenitor cells |
| 08/13/2008 | EP1956030A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/13/2008 | EP1955715A1 Use of Sirt7 for treating age-related diseases |
| 08/13/2008 | EP1955709A2 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/13/2008 | EP1954811A2 Inducible expression systems |
| 08/13/2008 | EP1768702A4 Preventing arrhythmias associated with cell transplantation |
| 08/13/2008 | EP1610765B1 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 08/13/2008 | EP1272636B1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 08/13/2008 | EP1251835B1 Closure of bacterial ghosts |
| 08/13/2008 | EP1214453B1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 08/13/2008 | EP1200117B1 Lipoprotein lipase (lpl) variant therapeutics |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP0894140B1 Allele suppression |
| 08/13/2008 | EP0831899B1 Recombinant poxvirus-calicivirus compositions and uses |
| 08/13/2008 | EP0669987B1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 08/13/2008 | CN101243184A Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 08/13/2008 | CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets |
| 08/13/2008 | CN101240292A Construction of human paraoxonase 3 gene expression vector |
| 08/13/2008 | CN101240289A Fowl infectious bronchitis virus S1 gene and fowl IL-2 gene coexpression DNA bacterin pIRES-S1/IL2 |
| 08/13/2008 | CN101240288A Fowl infectious bronchitis virus S1 gene and fowl IL-18 gene coexpression DNA bacterin pIRES-S1/IL18 |
| 08/13/2008 | CN101240287A Fowl infectious bronchitis virus M gene and fowl IL-18 gene coexpression DNA bacterin pIRES-M/IL18 |
| 08/13/2008 | CN101240275A Nucleic acid molecule SEPTIN1SR2 and application in producing immunity preparation |
| 08/13/2008 | CN101240274A Nucleic acid molecule SEPTIN1SR2 and application in preparing anti-leukemia medicament |
| 08/13/2008 | CN101240273A Nucleic acid molecule SEPTIN1SR1 and application in producing immunity preparation |
| 08/13/2008 | CN101240272A Nucleic acid molecule SEPTIN1SR1 and application in preparing anti-leukemia medicament |
| 08/13/2008 | CN101240271A Toll-like receptor adjustment oligonucleotide and use thereof |
| 08/13/2008 | CN101240262A Islet cells from human embryonic stem cells |
| 08/13/2008 | CN101240020A Breast cancer biological molecule marker LASS2 protein, modifying product and medical composition thereof |
| 08/13/2008 | CN101239711A Method for preparing gene transmission vector nano calcium phosphate |
| 08/13/2008 | CN100410382C Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response |
| 08/13/2008 | CN100410373C siRNA double-chain for suppressing bc1-2 gene expression |
| 08/13/2008 | CN100410273C Cancer-suppressing protein and its gene and uses |
| 08/13/2008 | CN100410268C Expression of immunogenic hepatitis B surface antigens in transgenic plants |
| 08/13/2008 | CN100409900C New use of staphylococcal enterotoxin A gene and its coded protein |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7410954 Adenovirus serotype 30 (Ad30) |
| 08/12/2008 | US7410953 Anticancer agent |
| 08/12/2008 | US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 08/12/2008 | US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 08/12/2008 | US7410776 Novel ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; use treating HIV infection, cancer, and various other diseases and disorders |
| 08/12/2008 | US7410773 Method of preparing an undifferentiated cell |
| 08/12/2008 | US7410759 Compositions and methods for diagnosing and treating mood disorders |
| 08/12/2008 | US7410757 Expressing nucleic acid in tissue from occipital cortex of brain showing cell death as result of Alzheimer's Disease; isolating suppressor gene |
| 08/12/2008 | US7410644 Recombinant pox virus for immunization against tumor-associated antigens |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 08/12/2008 | CA2376236C Modification of biological elements |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |